JP2018172409A5 - 15−hepeを含む組成物および同組成物を使用する方法 - Google Patents
15−hepeを含む組成物および同組成物を使用する方法 Download PDFInfo
- Publication number
- JP2018172409A5 JP2018172409A5 JP2018121494A JP2018121494A JP2018172409A5 JP 2018172409 A5 JP2018172409 A5 JP 2018172409A5 JP 2018121494 A JP2018121494 A JP 2018121494A JP 2018121494 A JP2018121494 A JP 2018121494A JP 2018172409 A5 JP2018172409 A5 JP 2018172409A5
- Authority
- JP
- Japan
- Prior art keywords
- hepe
- compositions
- methods
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WLKCSMCLEKGITB-XWJJKCKWSA-N 15-HEPE Chemical compound CC\C=C/CC(O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O WLKCSMCLEKGITB-XWJJKCKWSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1301626.6A GB201301626D0 (en) | 2013-01-30 | 2013-01-30 | Composition comprising 15-OHEPA and methods of using the same |
GB1301626.6 | 2013-01-30 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015555661A Division JP6363104B2 (ja) | 2013-01-30 | 2014-01-24 | 15−ohepaを含む組成物および同組成物を使用する方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018172409A JP2018172409A (ja) | 2018-11-08 |
JP2018172409A5 true JP2018172409A5 (ja) | 2019-05-16 |
Family
ID=47891001
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015555661A Expired - Fee Related JP6363104B2 (ja) | 2013-01-30 | 2014-01-24 | 15−ohepaを含む組成物および同組成物を使用する方法 |
JP2018121494A Pending JP2018172409A (ja) | 2013-01-30 | 2018-06-27 | 15−ohepaを含む組成物および同組成物を使用する方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015555661A Expired - Fee Related JP6363104B2 (ja) | 2013-01-30 | 2014-01-24 | 15−ohepaを含む組成物および同組成物を使用する方法 |
Country Status (28)
Country | Link |
---|---|
US (5) | US20150224076A1 (ja) |
EP (2) | EP2762143B1 (ja) |
JP (2) | JP6363104B2 (ja) |
KR (5) | KR102274963B1 (ja) |
CN (2) | CN105120872B (ja) |
AU (2) | AU2014211628B2 (ja) |
BR (1) | BR112015018270A2 (ja) |
CA (1) | CA2897343C (ja) |
CY (1) | CY1117209T1 (ja) |
DK (1) | DK2762143T3 (ja) |
ES (2) | ES2564025T3 (ja) |
GB (1) | GB201301626D0 (ja) |
HK (1) | HK1200351A1 (ja) |
HR (1) | HRP20160203T1 (ja) |
HU (1) | HUE026901T2 (ja) |
IL (3) | IL239893A (ja) |
MX (2) | MX364646B (ja) |
NZ (1) | NZ709803A (ja) |
PH (1) | PH12015501582A1 (ja) |
PL (1) | PL2762143T3 (ja) |
PT (1) | PT2762143E (ja) |
RS (1) | RS54584B1 (ja) |
RU (2) | RU2671208C2 (ja) |
SG (2) | SG10201806854XA (ja) |
SI (1) | SI2762143T1 (ja) |
SM (1) | SMT201600069B (ja) |
WO (1) | WO2014118097A1 (ja) |
ZA (2) | ZA201505018B (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
GB201301626D0 (en) * | 2013-01-30 | 2013-03-13 | Dignity Sciences Ltd | Composition comprising 15-OHEPA and methods of using the same |
JP2016538288A (ja) | 2013-11-15 | 2016-12-08 | ディグニティ サイエンシス リミテッド | 多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩 |
WO2015106215A2 (en) * | 2014-01-10 | 2015-07-16 | Mehar Manku | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same |
MA41120A (fr) * | 2014-12-02 | 2017-10-10 | Afimmune Ltd | Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci |
EP3247348A1 (en) * | 2015-01-16 | 2017-11-29 | Afimmune Limited | Compositions comprising 15-hepe and methods of using the same |
US20180104201A1 (en) | 2015-04-28 | 2018-04-19 | Pronova Biopharma Norge As | Use of structurally enhanced fatty acids containing sulphur for preventing and or treating non alcoholic steatohepatitis |
CN117402059A (zh) * | 2015-05-13 | 2024-01-16 | Ds生物制药有限公司 | 包含15-氧代-epa或15-氧代-dgla的组合物及其制备和使用方法 |
CN112245420A (zh) * | 2015-07-21 | 2021-01-22 | 艾菲穆恩有限公司 | 用于治疗或预防癌症和神经疾病的包括15-hepe的组合物 |
MX2018007390A (es) | 2015-12-18 | 2018-11-09 | Afimmune Ltd | Composiciones que comprenden acido 15-hidroxi eicosapentaenoico (15-hepe) y metodos de uso del mismo. |
KR20200096791A (ko) | 2017-12-06 | 2020-08-13 | 바스프 에이에스 | 비알콜성 지방간염 치료용 지방산 유도체 |
CN115215725A (zh) * | 2021-04-15 | 2022-10-21 | 宋晓瑜 | 一种制备乙酸薰衣草酯及薰衣草醇的方法 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05186342A (ja) * | 1992-01-10 | 1993-07-27 | Fujirebio Inc | 免疫調節作用を併せもつ抗炎症剤 |
AU673700B2 (en) | 1993-01-27 | 1996-11-21 | Scotia Holdings Plc | Triglycerides |
CA2149653C (en) | 1993-10-01 | 1999-02-23 | Frank S. S. Morton | Methods and compositions for dispensing fragrances |
US20020055539A1 (en) * | 1996-10-02 | 2002-05-09 | Bockow Barry I. | Compositions and methods for treating cardiovascular conditions |
WO1999058120A1 (en) * | 1998-05-08 | 1999-11-18 | Rolf Berge | USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
JP2000191525A (ja) | 1998-12-25 | 2000-07-11 | Nof Corp | 皮膚外用剤組成物 |
DE60124256T3 (de) | 2000-02-16 | 2012-09-20 | The Brigham And Women's Hospital Inc. | Aspirin-ausgelöste lipidmediatoren |
US20040043013A1 (en) | 2000-12-28 | 2004-03-04 | Mccleary Edward Larry | Metabolic uncoupling therapy |
HUP0401343A3 (en) | 2001-05-30 | 2008-08-28 | Laxdale Ltd | Compositions containing coenzyme q and eicosapentaenoic acid (epa) and their use |
CN1250230C (zh) * | 2001-09-30 | 2006-04-12 | 中国药品生物制品检定所 | 海狗油作为制备治脂肪肝药的应用 |
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
JP2005179211A (ja) | 2003-12-17 | 2005-07-07 | Idemitsu Kosan Co Ltd | 皮膚外用剤組成物 |
EP1711173A2 (en) | 2003-12-31 | 2006-10-18 | Igennus Limited | Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or ester thereof |
WO2005102309A2 (en) | 2004-04-26 | 2005-11-03 | Ltb4 Sweden Ab | In vivo release of endogenous anti-microbial mediators by leukotriene b4 (ltb4) administration |
US20050282781A1 (en) | 2004-06-18 | 2005-12-22 | Shibnath Ghosal | Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids |
CA2572344A1 (en) | 2004-07-01 | 2006-01-19 | Schepens Eye Research | Compositions and methods for treating eye disorders and conditions |
EP1973536A2 (en) * | 2006-01-05 | 2008-10-01 | Reliant Pharmaceuticals, Inc. | Treatment of fatty liver |
BRPI0715402A2 (pt) | 2006-08-08 | 2013-11-26 | Lipomics Technologies Inc | Marcadores de doença hepática gordurosa não alcoólica (nafld) e esteatohepatite não alcoólica (nash) e métodos de uso dos mesmos |
US20100120914A1 (en) * | 2007-03-30 | 2010-05-13 | Kowa Company, Ltd. | Medicament for prophylactic and/or therapeutic treatment of hepatic steatosis or non-alcoholic steatohepatitis |
GB0802116D0 (en) | 2008-02-05 | 2008-03-12 | Natural Enviromental Res Counc | Treatment |
JPWO2009154230A1 (ja) * | 2008-06-17 | 2011-12-01 | 持田製薬株式会社 | 非アルコール性脂肪肝炎の予防/改善・治療薬 |
WO2010095706A1 (ja) * | 2009-02-20 | 2010-08-26 | 国立大学法人東京大学 | 新規抗炎症性化合物 |
GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
CA2690488C (en) | 2010-01-19 | 2013-06-11 | Accucaps Industries Limited | Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
US9238634B2 (en) * | 2010-08-19 | 2016-01-19 | The University Of Tokyo | Anti-inflammatory metabolite derived from omega-3-type fatty acid |
WO2012031125A2 (en) | 2010-09-01 | 2012-03-08 | The General Hospital Corporation | Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine |
US10154977B2 (en) | 2011-03-25 | 2018-12-18 | The Brigham And Women's Hospital, Inc. | Anti-inflammatory particles |
US20120264824A1 (en) | 2011-04-15 | 2012-10-18 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
US8936803B2 (en) | 2011-10-19 | 2015-01-20 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof |
US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
CA2856715A1 (en) | 2011-11-29 | 2013-06-06 | Dignity Sciences Limited | Compositions comprising 20-carbon fatty acids and methods of making and using same |
US20150004224A1 (en) | 2012-01-06 | 2015-01-01 | Omthera Phrmaceuticals, Inc. | Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form |
US20120264705A1 (en) | 2012-01-26 | 2012-10-18 | Dignity Sciences Limited | Antimicrobial compositions comprising 15-hetre and methods of use thereof |
US20130267598A1 (en) | 2012-02-23 | 2013-10-10 | Dignity Sciences Limited | Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using same |
AU2013259503B2 (en) * | 2012-05-10 | 2017-03-16 | Solutex Na Llc | Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors |
GB201213484D0 (en) * | 2012-07-30 | 2012-09-12 | Dignity Sciences Ltd | Pharmaceutical compositions comprising 15-OHEPA and methods of using the same |
GB201301626D0 (en) * | 2013-01-30 | 2013-03-13 | Dignity Sciences Ltd | Composition comprising 15-OHEPA and methods of using the same |
MA41120A (fr) | 2014-12-02 | 2017-10-10 | Afimmune Ltd | Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci |
MX2018007390A (es) | 2015-12-18 | 2018-11-09 | Afimmune Ltd | Composiciones que comprenden acido 15-hidroxi eicosapentaenoico (15-hepe) y metodos de uso del mismo. |
-
2013
- 2013-01-30 GB GBGB1301626.6A patent/GB201301626D0/en not_active Ceased
- 2013-07-15 DK DK13176516.6T patent/DK2762143T3/en active
- 2013-07-15 ES ES13176516.6T patent/ES2564025T3/es active Active
- 2013-07-15 EP EP13176516.6A patent/EP2762143B1/en active Active
- 2013-07-15 PL PL13176516T patent/PL2762143T3/pl unknown
- 2013-07-15 HU HUE13176516A patent/HUE026901T2/en unknown
- 2013-07-15 RS RS20160118A patent/RS54584B1/en unknown
- 2013-07-15 ES ES15197389T patent/ES2759448T3/es active Active
- 2013-07-15 PT PT131765166T patent/PT2762143E/pt unknown
- 2013-07-15 EP EP15197389.8A patent/EP3058943B1/en active Active
- 2013-07-15 SI SI201330140T patent/SI2762143T1/sl unknown
-
2014
- 2014-01-24 KR KR1020157020952A patent/KR102274963B1/ko active IP Right Grant
- 2014-01-24 KR KR1020227028323A patent/KR102514913B1/ko active IP Right Grant
- 2014-01-24 RU RU2015136849A patent/RU2671208C2/ru active
- 2014-01-24 SG SG10201806854XA patent/SG10201806854XA/en unknown
- 2014-01-24 CN CN201480006443.XA patent/CN105120872B/zh active Active
- 2014-01-24 CN CN201911258822.9A patent/CN111214464A/zh active Pending
- 2014-01-24 AU AU2014211628A patent/AU2014211628B2/en not_active Ceased
- 2014-01-24 JP JP2015555661A patent/JP6363104B2/ja not_active Expired - Fee Related
- 2014-01-24 KR KR1020217020740A patent/KR102434817B1/ko active IP Right Grant
- 2014-01-24 BR BR112015018270A patent/BR112015018270A2/pt not_active Application Discontinuation
- 2014-01-24 SG SG11201505457PA patent/SG11201505457PA/en unknown
- 2014-01-24 CA CA2897343A patent/CA2897343C/en active Active
- 2014-01-24 MX MX2015009803A patent/MX364646B/es active IP Right Grant
- 2014-01-24 KR KR1020247001131A patent/KR20240011872A/ko active Application Filing
- 2014-01-24 WO PCT/EP2014/051455 patent/WO2014118097A1/en active Application Filing
- 2014-01-24 RU RU2018136872A patent/RU2018136872A/ru not_active Application Discontinuation
- 2014-01-24 NZ NZ709803A patent/NZ709803A/en not_active IP Right Cessation
- 2014-01-24 KR KR1020237009963A patent/KR20230047201A/ko not_active Application Discontinuation
-
2015
- 2015-01-29 HK HK15100996.7A patent/HK1200351A1/zh unknown
- 2015-04-24 US US14/695,865 patent/US20150224076A1/en not_active Abandoned
- 2015-07-12 IL IL239893A patent/IL239893A/en active IP Right Grant
- 2015-07-13 ZA ZA2015/05018A patent/ZA201505018B/en unknown
- 2015-07-16 PH PH12015501582A patent/PH12015501582A1/en unknown
- 2015-07-29 MX MX2019005082A patent/MX2019005082A/es unknown
-
2016
- 2016-02-25 CY CY20161100155T patent/CY1117209T1/el unknown
- 2016-02-26 HR HRP20160203T patent/HRP20160203T1/hr unknown
- 2016-03-08 SM SM201600069T patent/SMT201600069B/xx unknown
- 2016-07-21 ZA ZA2016/05125A patent/ZA201605125B/en unknown
-
2017
- 2017-04-06 IL IL251639A patent/IL251639A0/en active IP Right Grant
-
2018
- 2018-06-27 JP JP2018121494A patent/JP2018172409A/ja active Pending
- 2018-07-16 AU AU2018206685A patent/AU2018206685A1/en not_active Abandoned
-
2019
- 2019-04-07 IL IL265876A patent/IL265876A/en unknown
- 2019-07-31 US US16/527,841 patent/US10813903B2/en active Active
-
2020
- 2020-09-16 US US17/022,180 patent/US20210228524A1/en not_active Abandoned
-
2021
- 2021-04-16 US US17/232,862 patent/US20210244697A1/en not_active Abandoned
-
2022
- 2022-03-23 US US17/702,294 patent/US20220347147A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018172409A5 (ja) | 15−hepeを含む組成物および同組成物を使用する方法 | |
DK3595653T3 (da) | Sammensætninger af plinabulin og anvendelse heraf | |
GB2582482B (en) | CASZ compositions and methods of use | |
DK3559009T3 (da) | Sammensætninger og metoder til inhibition af arginaseaktivitet | |
MA50205A (fr) | Formulation de nicotine | |
DK3478811T3 (da) | Rengøringssammensætninger og anvendelser deraf | |
MA46481A (fr) | Compositions d'oligonucléotides et méthodes associées | |
DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
GB2582100B (en) | CAS12C Compositions and methods of use | |
EP3576782A4 (en) | COMPOSITIONS OF RECOMBINATION PRODUCT-PEPTIDE AND THEIR METHODS OF USE | |
DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
MA47611A (fr) | Compositionset méthodes de transduction tumorale | |
DK3606929T3 (da) | Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme | |
ZA202100780B (en) | Bismuth-thiol compositions and methods of use | |
MA54143A (fr) | Compositions et méthodes | |
IL276135A (en) | Preparations and methods of use | |
ZA201906169B (en) | Synthekine compositions and methods of use | |
KR20220035877A (ko) | Cd33 변형을 위한 조성물 및 방법 | |
IL283968A (en) | Benzamides of pyrazole-amino-pyrimidine type substances and their use | |
DK3288379T3 (da) | Peptidsammensætninger og anvendelsesmåder | |
DK3398598T3 (da) | Sulfonamidderivat og fremstillingsmetode og anvendelse deraf | |
SG11202011274YA (en) | Chemical compositions and methods of using same | |
EP3574047A4 (en) | EMULSION COMPOSITIONS AND METHOD FOR USE THEREOF | |
GB2568562B (en) | Moldable compositions and methods of using thereof | |
DK3678644T3 (da) | Formuleringer af copanlisib |